Global Parkinson’s Disease Treatment Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Carbidopa-Levodopa, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors, and Others), By Route of Administration (Oral, Subcutaneous, Transdermal, and Others), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
Industry: Healthcare
Need help to buy this report?
Inquiry Before Buy